Abstract
Objectives To determine the incremental net health benefits of dabigatran etexilate 110 mg and 150 mg twice daily and warfarin in patients with non-valvular atrial fibrillation and to estimate the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have